This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1go9
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
[[Image:1go9.png|left|200px]] | [[Image:1go9.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[1go9]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GO9 OCA]. | |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:12473096</ref><references group="xtra"/> | + | <ref group="xtra">PMID:12473096</ref><ref group="xtra">PMID:8386360</ref><references group="xtra"/> |
[[Category: Cordopatis, P.]] | [[Category: Cordopatis, P.]] | ||
[[Category: Pairas, G.]] | [[Category: Pairas, G.]] | ||
| Line 29: | Line 28: | ||
[[Category: Spyroulias, G A.]] | [[Category: Spyroulias, G A.]] | ||
[[Category: Corticotropin releasing hormone]] | [[Category: Corticotropin releasing hormone]] | ||
| + | [[Category: Hormone]] | ||
[[Category: Nmr]] | [[Category: Nmr]] | ||
[[Category: Solid phase synthesis]] | [[Category: Solid phase synthesis]] | ||
[[Category: Solutions structure]] | [[Category: Solutions structure]] | ||
[[Category: Synthetic analogue]] | [[Category: Synthetic analogue]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 14:04:38 2009'' | ||
Revision as of 23:03, 14 March 2011
MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS.
Template:ABSTRACT PUBMED 12473096
About this Structure
1go9 is a 1 chain structure. Full experimental information is available from OCA.
Reference
- Spyroulias GA, Papazacharias S, Pairas G, Cordopatis P. Monitoring the structural consequences of Phe12-->D-Phe and Leu15-->Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists. Eur J Biochem. 2002 Dec;269(24):6009-19. PMID:12473096
- Romier C, Bernassau JM, Cambillau C, Darbon H. Solution structure of human corticotropin releasing factor by 1H NMR and distance geometry with restrained molecular dynamics. Protein Eng. 1993 Feb;6(2):149-56. PMID:8386360
